Agios制药(AGIO)

29.01 -0.11 -0.3777%

今开:29.19昨收:29.12
最高:29.27 最低:28.815
涨停价:0.0跌停价:0.0
总市值:1.630212511E9

Agios制药的热门讨论

产业链观察01-03 20:43

#药闻简讯# $Agios制药(AGIO)$ 对非输血依赖型阿尔法或贝塔地中海贫血成人患者进行的 Mitapivat 3 期 ENERGIZE 研究达到了主要终点和两个关键次要终点。关键次要终点也具有统计学意义查看全文

产业链观察01-04 09:20

#药闻简讯# 2024年1月3日(美国密歇根州)细胞代谢领域的领先企业、罕见病治疗领域的开拓者$Agios制药(AGIO)$ 今天宣布,针对非输血依赖型(NTD)α-或β-地中海贫血成人患者的米他米韦全球3期ENERGIZE研究达到了血红蛋白反应的主要终点。 FACIT-疲劳评分和血红蛋白浓度与基线相比的变化这两个关键...查看全文

持股变动声明

Agios制药(AGIO)2023-08-12 04:15

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-23-000125  Size: 9 KB 网页链接查看全文

持股变动声明

Agios制药(AGIO)2023-07-01 04:15

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-23-000107  Size: 8 KB 网页链接查看全文

当期报告

Agios制药(AGIO)2023-05-04 19:06

$Agios制药(AGIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001439222-23-000063  Act: 34  Size: 325 KB 网页链接查看全文

年度财报

Agios制药(AGIO)2023-02-23 23:42

$Agios制药(AGIO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001439222-23-000039  Act: 34  Size: 11 MB 网页链接查看全文

超过5%股东持股披露「修订」

Agios制药(AGIO)2023-02-15 01:51

$Agios制药(AGIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000080255-23-002609  Act: 34  Size: 7 KB 网页链接查看全文

持股变动声明

Agios制药(AGIO)2023-02-15 05:28

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-23-000017  Size: 8 KB 网页链接查看全文

当期报告

Agios制药(AGIO)2022-11-03 19:06

$Agios制药(AGIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001439222-22-000098  Act: 34  Size: 349 KB 网页链接查看全文

持股变动声明

Agios制药(AGIO)03-08 07:55

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000058  Size: 7 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

Agios制药的公告

持股变动声明

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000061  Size: 5 KB 网页链接

持股变动声明

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000056  Size: 4 KB 网页链接

持股变动声明

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000058  Size: 7 KB 网页链接

证券出售报告

$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002026  Act: 33  Size: 6 KB 网页链接

证券出售报告

$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001982  Act: 33  Size: 6 KB 网页链接

证券出售报告

$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001926  Act: 33  Size: 5 KB 网页链接

持股变动声明

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000050  Size: 16 KB 网页链接

持股变动声明

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000052  Size: 13 KB 网页链接

持股变动声明

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000054  Size: 18 KB 网页链接

持股变动声明

$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000044  Size: 7 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97